COMT genetic variants and pain

Drugs of Today

Volumn 47, Issue 6, 2011, Pages 457-467

  Belfer, Inna ^a   Segall, S ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOL METHYLTRANSFERASE; DOPAMINE; MESSENGER RNA; MORPHINE; NARCOTIC ANALGESIC AGENT; NORADRENALIN; PROPRANOLOL;

AMINO ACID SUBSTITUTION; CHRONIC PAIN; COGNITION; CONFUSION; DNA POLYMORPHISM; DROWSINESS; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME METABOLISM; FIBROMYALGIA; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HALLUCINATION; HAPLOTYPE; HEADACHE; HUMAN; MIGRAINE; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PHARMACOGENETICS; PLEIOTROPY; POSTOPERATIVE PAIN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CATECHOL O-METHYLTRANSFERASE; GENETIC VARIATION; HUMANS; NEURALGIA; PAIN;

EID: 80052773921     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2011.47.6.1611895     Document Type: Review

References (76)

1. Max, M.B., Stewart, W.F. The molecular epidemiology of pain: a new discipline for drug discovery. Nat Rev Drug Discov 2008, 7(8): 647-58.
2. Diatchenko, L., Nackley, A.G., Tchivileva, I.E., Shabalina, S.A., Maixner, W. Genetic architecture of human pain perception. Trends Genet 2007, 23(12): 605-13.
3. Bai, H.W., Shim, J.Y., Yu, J., Zhu, B.T. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol- O-methyltransferases. Chem Res Toxicol 2007, 20(10): 1409-25.
4. Mukherjee, N., Kidd, K.K., Pakstis, A.J. et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O- methyltransferase. Mol Psychiatry 2010, 15(2): 216-25.
5. Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., Taskinen, J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995, 34(13): 4202-10.
6. Lachman, H.M., Papolos, D.F., Saito, T., Yu, Y.M., Szumlanski, C.L., Weinshilboum, R.M. Human catechol-Omethyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6(3): 243-50.
7. Weinshilboum, R.M. Pharmacogenomics: catechol Omethyltransferase to thiopurine S-methyltransferase. Cell Mol Neurobiol 2006, 26(4-6): 539-61.
8. Gabriel, S.B., Schaffner, S.F., Nguyen, H. et al. The structure of haplotype blocks in the human genome. Science 2002, 296(5576): 2225-9.
9. Diatchenko, L., Slade, G.D., Nackley, A.G. et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005, 14(1): 135-43.
10. Nackley, A.G., Shabalina, S.A., Tchivileva, I.E. et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314(5807): 1930-3.
11. Nackley, A.G., Diatchenko, L. Assessing potential functionality of catechol-O-methyltransferase (COMT) polymorphisms associated with pain sensitivity and temporomandibular joint disorders. Methods Mol Biol 2010, 617: 375-93.
12. Nackley, A.G., Shabalina, S.A., Lambert, J.E. et al. Low enzymatic activity haplotypes of the human catechol-Omethyltransferase gene: enrichment for marker SNPs. PLoS One 2009, 4(4): e5237.
13. Voelker, P., Sheese, B.E., Rothbart, M.K., Posner, M.I. Variations in catechol-O-methyltransferase gene interact with parenting to influence attention in early development. Neuroscience 2009, 164(1): 121-30.
14. Hosak, L. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry 2007, 22(5): 276-81.
15. Heinz, A., Smolka, M.N. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev Neurosci 2006, 17(3): 359-67.
16. Derijk, R.H. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 2009, 16(5): 340-52.
17. Zubieta, J.K., Heitzeg, M.M., Smith, Y.R. et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299(5610): 1240-3.
18. Mobascher, A., Brinkmeyer, J., Thiele, H. et al. The val158met polymorphism of human catechol-O-methyltransferase (COMT) affects anterior cingulate cortex activation in response to painful laser stimulation. Mol Pain 2010, 6: 32.
19. Lee, T.W., Yu, Y.W., Hong, C.J., Tsai, S.J., Wu, H.C., Chen, T.J. The effects of catechol-O-methyl-transferase polymorphism Val158Met on functional connectivity in healthy young females: a resting EEG study. Brain Res 2011, 1377: 21-31.
20. Xu, K., Ernst, M., Goldman, D. Imaging genomics applied to anxiety, stress response, and resiliency. Neuroinformatics 2006, 4(1): 51-64.
21. Kim, H., Mittal, D.P., Iadarola, M.J., Dionne, R.A. Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet 2006, 43(8): e40.
22. Birklein, F., Depmeier, C., Rolke, R., Hansen, C., Rautenstrauss, B., Prawitt, D., Magerl, W. A family-based investigation of cold pain tolerance. Pain 2008, 138(1): 111-8.
23. Potvin, S., Larouche, A., Normand, E., de Souza, J.B., Gaumond, I., Grignon, S., Marchand, S. DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain 2009, 10(9): 969-75.
24. Diatchenko, L., Nackley, A.G., Slade, G.D. et al. Catechol- Omethyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006, 125(3): 216-24.
25. Sand, P.G., Korte, G., Domani, M., Konstandin, N., Karl, A., Wagner, K., Dinnbier, M. Alternatively spliced human catechol- O-methyltransferase (COMT) rationalizes lack of Val158Met effects on pain tolerance. Pain 2008, 136(3): 445-6.
26. Vossen, H., Kenis, G., Rutten, B., van Os, J., Hermens, H., Lousberg, R. The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS One 2010, 5(10): e13641.
27. McLean, S.A., Diatchenko, L., Lee, Y.M. et al. Catechol Omethyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain 2011, 12(1): 101-7.
28. Hagen, K., Pettersen, E., Stovner, L.J., Skorpen, F., Zwart, J.A. No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-Omethyltransferase gene. The HUNT study. BMC Musculoskelet Disord 2006, 7: 40.
29. Nicholl, B.I., Holliday, K.L., Macfarlane, G.J. et al. No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain. Ann Rheum Dis 2011, 69(11): 2009-12.
30. Hocking, L.J., Smith, B.H., Jones, G.T., Reid, D.M., Strachan, D.P., Macfarlane, G.J. Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort Study. Pain 2010, 149(1): 143-51.
31. Jakobi, J., Bernateck, M., Tran, A.T. et al. Catechol-O-methyltransferase gene polymorphisms are not associated with multisomatoform disorder in a group of German multisomatoform disorder patients and healthy controls. Genet Test Mol Biomarkers 2010, 14(3): 293-7.
32. Cohen, H., Neumann, L., Glazer, Y., Ebstein, R.P., Buskila, D. The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clin Exp Rheumatol 2009, 27(5, Suppl. 56): S51-6.
33. Barbosa, F.R., Matsuda, J.B., Mazucato, M. et al. Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromyalgia patients. Rheumatol Int 2010, Advance publication.
34. Vargas-Alarcon, G., Fragoso, J.M., Cruz-Robles, D. et al. Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 2007, 9(5): R110.
35. Finan, P.H., Zautra, A.J., Davis, M.C., Lemery-Chalfant, K., Covault, J., Tennen, H. COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain 2011, 152(2): 300-7.
36. Finan, P.H., Zautra, A.J., Davis, M.C., Lemery-Chalfant, K., Covault, J., Tennen, H. Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol 2010, 29(2): 134-42.
37. Matsuda, J.B., Barbosa, F.R., Morel, L.J. et al. Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Rev Bras Reumatol 2010, 50(2): 141-9.
38. Emin Erdal, M., Herken, H., Yilmaz, M., Bayazit, Y.A. Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Res Mol Brain Res 2001, 94(1- 2): 193-6.
39. Hagen, K., Pettersen, E., Stovner, L.J., Skorpen, F., Zwart, J.A. The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene: the HUNT Study. J Headache Pain 2006, 7(2): 70-4.
40. Cevoli, S., Mochi, M., Scapoli, C. et al. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 2006, 13(9): 1009-13.
41. Park, J.W., Lee, K.S., Kim, J.S., Kim, Y.I., Shin, H.E. Genetic contribution of catechol-O-methyltransferase polymorphism in patients with migraine without aura. J Clin Neurol 2007, 3(1): 24-30.
42. Kim, H., Lee, H., Rowan, J., Brahim, J., Dionne, R.A. Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Mol Pain 2006, 2: 24.
43. Dai, F., Belfer, I., Schwartz, C.E. et al. Association of catechol- O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J 2010, 10(11): 949-57.
44. George, S.Z., Wallace, M.R., Wright, T.W. et al. Evidence for a biopsychosocial influence on shoulder pain: pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain ratings. Pain 2008, 136(1-2): 53-61.
45. George, S.Z., Dover, G.C., Wallace, M.R., Sack, B.K., Herbstman, D.M., Aydog, E., Fillingim, R.B. Biopsychosocial influence on exercise-induced delayed onset muscle soreness at the shoulder: pain catastrophizing and catechol-Omethyltransferase (COMT) diplotype predict pain ratings. Clin J Pain 2008, 24(9): 793-801.
46. Fijal, B., Perlis, R.H., Heinloth, A.N., Houston, J.P. The association of single nucleotide polymorphisms in the catechol-Omethyltransferase gene and pain scores in female patients with major depressive disorder. J Pain 2010, 11(9): 910-5, 5 e1-9.
47. Perlis, R.H., Fijal, B., Adams, D.H., Sutton, V.K., Trivedi, M.H., Houston, J.P. Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder. Biol Psychiatry 2009, 65(9): 785-91.
48. Armero, P., Muriel, C., Santos, J., Sanchez-Montero, F.J., Rodriguez, R.E., Gonzalez-Sarmiento, R. COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population. Eur J Pain 2005, 9(3): 229-32.
49. Mylius, V., Moller, J.C., Strauch, K., Oertel, W.H., Stiasny- Kolster, K. No significance of the COMT val158met polymorphism in restless legs syndrome. Neurosci Lett 2010, 473(2): 151-4.
50. Segall, S.K., Nackley, A.G., Diatchenko, L. et al. Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of mice. Genes Brain Behav 2010, 9(8): 933-46.
51. Kember, R.L., Fernandes, C., Tunbridge, E.M., Liu, L., Paya- Cano, J.L., Parsons, M.J., Schalkwyk, L.C. A B2 SINE insertion in the Comt1 gene (Comt1(B2i)) results in an overexpressing, behavior modifying allele present in classical inbred mouse strains. Genes Brain Behav 2010, 9(8): 925-32.
52. Li, Z., Mulligan, M.K., Wang, X., Miles, M.F., Lu, L., Williams, R.W. A transposon in comt generates mRNA variants and causes widespread expression and behavioral differences among mice. PLoS One 2010, 5(8): e12181.
53. Papaleo, F., Crawley, J.N., Song, J., Lipska, B.K., Pickel, J., Weinberger, D.R., Chen, J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 2008, 28(35): 8709-23.
54. Weinshilboum, R., Raymond, F. Variations in catechol-Omethyltransferase activity in inbred strains of rats. Neuropharmacology 1977, 16(10): 703-6.
55. Weinshilboum, R.M., Raymond, F.A., Frohnauer, M. Monogenic inheritance of catechol-O-methyltransferase activity in the rat - biochemical and genetic studies. Biochem Pharmacol 1979, 28(7): 1239-47.
56. Goldstein, D.J., Weinshilboum, R.M., Dunnette, J.H., Creveling, C.R. Developmental patterns of catechol-Omethyltransferase in genetically different rat strains: enzymatic and immunochemical studies. J Neurochem 1980, 34(1): 153-62.
57. Lariviere, W.R., Sattar, M.A., Melzack, R. Inflammation-susceptible Lewis rats show less sensitivity than resistant Fischer rats in the formalin inflammatory pain test and with repeated thermal testing. J Neurophysiol 2006, 95(5): 2889-97.
58. Tammimaki, A., Kaenmaki, M., Kambur, O. et al. Effect of SCOMT deficiency on behavior and extracellular brain dopamine concentrations in mice. Psychopharmacology (Berl) 2010, 211(4): 389-401.
59. Herradon, G., Ezquerra, L., Nguyen, T. et al. Changes in BDNF gene expression correlate with rat strain differences in neuropathic pain. Neurosci Lett 2007, 420(3): 273-6.
60. Herradon, G., Ezquerra, L., Nguyen, T. et al. Noradrenergic and opioidergic alterations in neuropathy in different rat strains. Neurosci Lett 2008, 438(2): 186-9.
61. Nackley, A.G., Tan, K.S., Fecho, K., Flood, P., Diatchenko, L., Maixner, W. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 2007, 128(3): 199-208.
62. Tchivileva, I.E., Nackley, A.G., Qian, L., Wentworth, S., Conrad, M., Diatchenko, L.B. Characterization of NF-kBmediated inhibition of catechol-O-methyltransferase. Mol Pain 2009, 5: 13.
63. Oertel, B., Lotsch, J. Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics 2008, 9(2): 179-94.
64. Rakvag, T.T., Klepstad, P., Baar, C. et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 2005, 116(1-2): 73-8.
65. Rakvag, T.T., Ross, J.R., Sato, H., Skorpen, F., Kaasa, S., Klepstad, P. Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain 2008, 4: 64.
66. Ross, J.R., Riley, J., Taegetmeyer, A.B., Sato, H., Gretton, S., du Bois, R.M., Welsh, K.I. Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer 2008, 112(6): 1390-403.
67. Jensen, K.B., Lonsdorf, T.B., Schalling, M., Kosek, E., Ingvar, M. Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism. PLoS One 2009, 4(6): e6016.
68. Lotsch, J., von Hentig, N., Freynhagen, R. et al. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. Pharmacogenet Genomics 2009, 19(6): 429-36.
69. Lotsch, J., Fluhr, K., Neddermayer, T., Doehring, A., Geisslinger, G. The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain. Clin Pharmacol Ther 2009, 85(1): 25-30.
70. Mantione, K., Kream, R.M., Stefano, G.B. Variations in critical morphine biosynthesis genes and their potential to influence human health. Neuro Endocrinol Lett 2010, 31(1): 11-8.
71. Tchivileva, I.E., Lim, P.F., Smith, S.B., Slade, G.D., Diatchenko, L., McLean, S.A., Maixner, W. Effect of catechol- O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study. Pharmacogenet Genomics 2010, 20(4): 239-48.
72. Kolesnikov, Y., Gabovits, B., Levin, A., Voiko, E., Veske, A. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects. Anesth Analg 2011, 112(2): 448-53.
73. Stein, D.J., Newman, T.K., Savitz, J., Ramesar, R. Warriors versus worriers: the role of COMT gene variants. CNS Spectr 2006, 11(10): 745-8.
74. Egan, M.F., Goldberg, T.E., Kolachana, B.S. et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98(12): 6917-22.
75. Oroszi, G., Goldman, D. Alcoholism: genes and mechanisms. Pharmacogenomics 2004, 5(8): 1037-48.
76. Andersen, S., Skorpen, F. Variation in the COMT gene: implications for pain perception and pain treatment. Pharmacogenomics 2009, 10(4): 669-84.